The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer’s disease

BACKGROUND: Early-onset Alzheimer’s disease (EOAD) is characterized by young age of onset (< 65 years), severe neurodegeneration, and rapid disease progression, thus differing significantly from typical late-onset Alzheimer’s disease. Growing evidence suggests a primary role of neuroinflammation...

Descripción completa

Detalles Bibliográficos
Autores principales: Tondo, Giacomo, Iaccarino, Leonardo, Caminiti, Silvia Paola, Presotto, Luca, Santangelo, Roberto, Iannaccone, Sandro, Magnani, Giuseppe, Perani, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193377/
https://www.ncbi.nlm.nih.gov/pubmed/32354345
http://dx.doi.org/10.1186/s13195-020-00619-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193377/
https://www.ncbi.nlm.nih.gov/pubmed/32354345
http://dx.doi.org/10.1186/s13195-020-00619-0

Ejemplares similares